Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population

Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention

(2009) Paul S. Chan et al.  

Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials

(2009) Wayne C. Levy et al.   EUROPEAN JOURNAL OF HEART FAILURE

Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction

(2008) Michael R. Gold et al.   CIRCULATION

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

(2008) et al.   CIRCULATION

Patient and Implanting Physician Factors Associated With Mortality and Complications After Implantable Cardioverter-Defibrillator Implantation, 2002–2005

(2008) Sana M. Al-Khatib et al.   Circulation-Arrhythmia and Electrophysiology

Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction

(2008) Ilan Goldenberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Characteristics of “Stage D” heart failure: Insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM)

(2007) Maria R. Costanzo et al.   AMERICAN HEART JOURNAL